A股異動 | 中欣氟材(002915.SZ)漲超4% 擬定增募資不超5.2億元
格隆匯11月9日丨中欣氟材(002915.SZ)臨近尾盤突現拉昇,現報19.89元,漲4.74%,暫成交8033萬元,最新總市值40億元。中欣氟材昨日披露2020年度非公開發行A股股票預案,擬非公開發行股票的數量不超過此次發行前公司總股本的30%,即不超過6120.6136萬股(含本數),募集資金總額為不超過5.2億元(含本數)。扣除發行費用後,1億元用於年產5000噸4,4’-二氟二苯酮項目,3億元用於福建高寶礦業有限公司氟精細化學品系列擴建項目,1.2億元用於補充流動資金。公司表示,募投項目圍繞公司主營業務展開,是公司現有產品的拓展與延伸。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.